Generous support from people like you enable Peter Mac’s cancer research to continue. Each donation toward cancer research helps us find more effective treatments for people with cancer. At Peter Mac, over 650 laboratory scientists, clinician-researchers, research nurses and other health professionals are working together to discover new and better ways to fight cancer. With your support, our cancer experts are making important advances every day.
It is estimated that more than 1800 new cases of brain cancer were diagnosed in Australia in 2021. Treatment of brain cancer can vary and may include surgery, chemotherapy and radiation therapy.
For patients with some hard-to-treat blood cancers, a new immunotherapy is achieving promising results.
Twenty-four innovative Peter Mac cancer research projects were awarded 2022 Endowment Fund Grants.
Twenty-four innovative Peter Mac cancer research projects awarded 2021 Endowment Fund Grants
There’s now new hope for treating many types of tumours where chemotherapy has been ineffective.
Associate Professor Paul Neeson and his team have been exploring how, through immunotherapy, they can use a combination of drugs to stimulate the immune system and boost the body’s own defences against blood cancers, like multiple myeloma.
Twenty-two new ground-breaking Peter Mac cancer research projects will be established thanks to the generosity of donors to the Foundation’s Perpetual Endowment Fund.
A total of $1.26m in seed funding was awarded in 2018 to help kick-start some of Peter Mac's most innovative new cancer research initiatives.
Dr Kylie Gorringe, a cancer researcher at Peter Mac, wants to discover cancer cures that help all cancer patients. Your support helps her, and 600 other cancer researchers, do just that.
Prostate cancer takes the lives of almost 300 Australian men every month and is the second leading cause of male cancer deaths in Australia today. With support from donors like you, Peter Mac researchers are working together to change these statistics.
Our donors are helping Peter Mac researchers pioneer the development of a new combination drug therapy to treat advanced blood cancers, which currently claim the lives of around 4,000 Australians each year.
Blood tests may soon provide more accurate, predictive and less invasive disease monitoring for patients at risk of relapse following standard treatments for breast cancer.
The largest complete DNA analysis of ovarian cancer in the world, published overnight in Nature, has revealed unprecedented new insight into the genetic twists and turns a deadly form of the disease takes to outsmart chemotherapy, potentially changing treatment approaches for women around the world.
Peter Mac researchers are investigating how the immune system can be used to better identify, remember and kill invading cancer cells.
Researchers from Peter Mac have discovered an immune signal in breast cancer cells that could be targeted with an existing treatment to contain tumours before they metastasise.
Peter Mac researchers have pinpointed the beneficial impact of non-steroidal anti-inflammatory drugs (such as aspirin) on inhibiting the ability for tumours to spread in the body.
After an important discovery in our research laboratories, Peter Mac has begun world-first clinical trials of a new first-in-class compound to treat blood cancers.
